Autoimmune & Cancer Small Molecules
Antibody production, services
Research Antibodies & Peptides
Antibody, peptide, and assay product and service provider
Antibodies, Peptides, etc
Antibodies, clinical diagnostics, etc
in vivo monoclonal antibody discovery platform
Abraxis develops, manufactures, and markets rapid environmental, food, and life sciences test systems, including immunochemistry products and methods, to meet the testing needs of research and ...
Antibodies, Kits, etc
Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.
T Cell Receptor Analysis
Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...
Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...
Equipment and antibodies for immunoassays
Agenus uses the power of the immune system to develop innovative product candidates against cancer. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...
Alder BioPharmaceuticals is developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases. ...
Antibodies, Kits & Reagents
Biologics. Amgen makes several therapeutic drugs that target serious disease. Many are derived from engineered monoclonal antibodies. Some target immune receptors.
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
bi-functional antibody therapy
Antibodies, Assays, Development Services, Diagnostic kits,etc
Rabbit-derived humanized monoclonal antibodies
Uses modified antibodies to generate immunotherapeutics.
Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Monoclonal Antibody & Small Molecule Targeting Infectious Diseases
Fully human monoclonal antibodies
Recombinant T Cell Receptor Ligands
Antibody conjugates for cancer
Antibodies, ELISA kits, Assays Kits, dyes, assay/antibody services
Immune cell products for research
Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.
proprietary human antibody discovery platform
Yeast-Display Technology, Human Antibody Discovery
Antibodies, Peptides, Kits, etc
Antibodies, Sera, Enzymes, Contract Work, etc
A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.
Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...
Benaroya Research Institute's mission is to find the causes and cures of autoimmune diseases, including diabetes, lupus, cancer, MS, heart disease and others.
Develops antibody-based therapeutics
Antibodies, Immunoassays, Small Molecule